Shanghai Kinetic Medical Co (300326) - Net Assets

Latest as of September 2025: CN¥2.88 Billion CNY ≈ $421.82 Million USD

Based on the latest financial reports, Shanghai Kinetic Medical Co (300326) has net assets worth CN¥2.88 Billion CNY (≈ $421.82 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.38 Billion ≈ $494.36 Million USD) and total liabilities (CN¥495.68 Million ≈ $72.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Shanghai Kinetic Medical Co to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥2.88 Billion
% of Total Assets	85.33%
Annual Growth Rate	38.0%
5-Year Change	4.9%
10-Year Change	114.11%
Growth Volatility	92.92

Shanghai Kinetic Medical Co - Net Assets Trend (2008–2024)

This chart illustrates how Shanghai Kinetic Medical Co's net assets have evolved over time, based on quarterly financial data. Also explore Shanghai Kinetic Medical Co total assets for the complete picture of this company's asset base.

Annual Net Assets for Shanghai Kinetic Medical Co (2008–2024)

The table below shows the annual net assets of Shanghai Kinetic Medical Co from 2008 to 2024. For live valuation and market cap data, see Shanghai Kinetic Medical Co stock valuation.

Year	Net Assets	Change
2024-12-31	CN¥2.82 Billion ≈ $412.49 Million	-4.40%
2023-12-31	CN¥2.95 Billion ≈ $431.48 Million	+4.76%
2022-12-31	CN¥2.81 Billion ≈ $411.88 Million	+1.31%
2021-12-31	CN¥2.78 Billion ≈ $406.56 Million	+3.39%
2020-12-31	CN¥2.69 Billion ≈ $393.24 Million	-2.35%
2019-12-31	CN¥2.75 Billion ≈ $402.71 Million	+9.99%
2018-12-31	CN¥2.50 Billion ≈ $366.14 Million	+22.55%
2017-12-31	CN¥2.04 Billion ≈ $298.76 Million	+10.88%
2016-12-31	CN¥1.84 Billion ≈ $269.44 Million	+39.86%
2015-12-31	CN¥1.32 Billion ≈ $192.65 Million	+20.23%
2014-12-31	CN¥1.10 Billion ≈ $160.24 Million	+115.15%
2013-12-31	CN¥508.97 Million ≈ $74.48 Million	+14.40%
2012-12-31	CN¥444.92 Million ≈ $65.11 Million	+373.67%
2011-12-31	CN¥93.93 Million ≈ $13.75 Million	+22.30%
2010-12-31	CN¥76.80 Million ≈ $11.24 Million	+96.43%
2009-12-31	CN¥39.10 Million ≈ $5.72 Million	+139.91%
2008-12-31	CN¥16.30 Million ≈ $2.38 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Shanghai Kinetic Medical Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 8367.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥1.13 Billion	41.63%
Common Stock	CN¥717.03 Million	26.35%
Other Comprehensive Income	CN¥177.50 Million	6.52%
Other Components	CN¥693.59 Million	25.49%
Total Equity	CN¥2.72 Billion	100.00%

Shanghai Kinetic Medical Co Competitors by Market Cap

The table below lists competitors of Shanghai Kinetic Medical Co ranked by their market capitalization.

Company	Market Cap
COMSTOCK HLDG-A F:CHO	$744.97 Million
B Communications Ltd TA:BCOM	$745.08 Million
Zhejiang He Chuan Technology Corp. Ltd. A SHG:688320	$745.37 Million
Teyi Pharmaceutical Group Co Ltd SHE:002728	$745.43 Million
Tamar Petroleum Ltd TA:TMRP	$744.67 Million
Kuyas Yatirim AS IS:KUYAS	$744.49 Million
Tamboran Resources Corporation AU:TBN	$744.06 Million
Anhui Korrun Co Ltd SHE:300577	$744.03 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shanghai Kinetic Medical Co's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,859,842,987 to 2,720,915,236, a change of -138,927,751 (-4.9%).
Net loss of 105,565,367 reduced equity.
Dividend payments of 46,136,611 reduced retained earnings.
Other comprehensive income increased equity by 177,495,831.
Other factors decreased equity by 164,721,604.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥-105.57 Million	-3.88%
Dividends Paid	CN¥46.14 Million	-1.7%
Other Comprehensive Income	CN¥177.50 Million	+6.52%
Other Changes	CN¥-164.72 Million	-6.05%
Total Change	CN¥-	-4.86%

Book Value vs Market Value Analysis

This analysis compares Shanghai Kinetic Medical Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.87x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 160.56x to 1.87x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2008-12-31	CN¥0.04	CN¥7.10	x
2009-12-31	CN¥0.11	CN¥7.10	x
2010-12-31	CN¥0.19	CN¥7.10	x
2011-12-31	CN¥0.23	CN¥7.10	x
2012-12-31	CN¥0.92	CN¥7.10	x
2013-12-31	CN¥0.92	CN¥7.10	x
2014-12-31	CN¥1.81	CN¥7.10	x
2015-12-31	CN¥1.83	CN¥7.10	x
2016-12-31	CN¥2.63	CN¥7.10	x
2017-12-31	CN¥2.82	CN¥7.10	x
2018-12-31	CN¥3.48	CN¥7.10	x
2019-12-31	CN¥3.81	CN¥7.10	x
2020-12-31	CN¥3.76	CN¥7.10	x
2021-12-31	CN¥3.79	CN¥7.10	x
2022-12-31	CN¥3.81	CN¥7.10	x
2023-12-31	CN¥3.99	CN¥7.10	x
2024-12-31	CN¥3.79	CN¥7.10	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shanghai Kinetic Medical Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -3.88%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -10.72%
• Asset Turnover: 0.29x
• Equity Multiplier: 1.23x
Recent ROE (-3.88%) is below the historical average (17.92%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	83.41%	58.31%	1.23x	1.16x	CN¥11.96 Million
2009	45.82%	46.20%	0.74x	1.34x	CN¥14.00 Million
2010	46.36%	60.66%	0.66x	1.16x	CN¥27.92 Million
2011	39.53%	46.01%	0.69x	1.24x	CN¥27.74 Million
2012	12.48%	54.60%	0.22x	1.06x	CN¥11.03 Million
2013	12.58%	50.56%	0.21x	1.20x	CN¥13.15 Million
2014	5.96%	27.99%	0.17x	1.26x	CN¥-42.19 Million
2015	10.33%	26.06%	0.27x	1.45x	CN¥3.86 Million
2016	8.64%	28.85%	0.25x	1.21x	CN¥-25.04 Million
2017	9.62%	24.30%	0.30x	1.33x	CN¥-7.69 Million
2018	18.51%	49.69%	0.26x	1.43x	CN¥212.70 Million
2019	11.00%	24.73%	0.32x	1.37x	CN¥27.50 Million
2020	-4.79%	-11.92%	0.29x	1.39x	CN¥-390.84 Million
2021	5.92%	12.75%	0.36x	1.28x	CN¥-111.58 Million
2022	-0.78%	-1.83%	0.34x	1.25x	CN¥-295.24 Million
2023	3.94%	11.77%	0.29x	1.17x	CN¥-173.45 Million
2024	-3.88%	-10.72%	0.29x	1.23x	CN¥-377.66 Million

Industry Comparison

This section compares Shanghai Kinetic Medical Co's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,693,665,971
Average return on equity (ROE) among peers: 12.72%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Shanghai Kinetic Medical Co (300326)	CN¥2.88 Billion	83.41%	0.17x	$744.94 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$486.48 Million	24.26%	0.26x	$449.34 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$405.69 Million	15.24%	0.11x	$4.30 Billion
Double Medical Technology Inc (002901)	$3.16 Billion	1.87%	0.47x	$2.63 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$49.59 Million	43.44%	0.23x	$577.41 Million
Lepu Medical Tech Beijing (300003)	$6.01 Billion	11.30%	0.58x	$3.87 Billion
INKON Life Technology Co Ltd (300143)	$116.90 Million	17.41%	0.92x	$1.23 Billion
Edan Instruments Inc (300206)	$1.22 Billion	8.49%	0.19x	$1.26 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$1.39 Billion	-4.69%	0.82x	$685.28 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$1.45 Billion	0.44%	0.18x	$534.16 Million
Sinocare Inc (300298)	$2.65 Billion	9.46%	0.24x	$1.36 Billion

About Shanghai Kinetic Medical Co

SHE:300326 China Medical Devices

Market Cap

$744.94 Million

CN¥5.09 Billion CNY

Market Cap Rank

#10516 Global

#3075 in China

Share Price

CN¥7.10

Change (1 day)

+3.20%

52-Week Range

CN¥3.87 - CN¥7.10

All Time High

CN¥29.87